三鑫医疗
(300453)
| 流通市值：33.40亿 | | | 总市值：48.32亿 |
| 流通股本：3.61亿 | | | 总股本：5.22亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 760,807,967.78 | 360,576,957.37 | 1,500,438,417.74 | 1,082,325,012.3 |
| 营业收入 | 760,807,967.78 | 360,576,957.37 | 1,500,438,417.74 | 1,082,325,012.3 |
| 二、营业总成本 | 629,533,153.21 | 298,171,216 | 1,237,481,684.14 | 893,134,673.4 |
| 营业成本 | 494,731,989.9 | 235,743,644.7 | 970,338,340.01 | 703,175,490.86 |
| 税金及附加 | 6,817,932.27 | 3,137,856.61 | 12,326,561.24 | 8,820,225.96 |
| 销售费用 | 37,032,161.29 | 16,620,146.83 | 84,057,182.63 | 63,736,706.58 |
| 管理费用 | 57,583,518.2 | 26,825,689.68 | 107,953,051.15 | 73,168,404.16 |
| 研发费用 | 33,178,724.9 | 16,250,108.87 | 63,977,820.58 | 44,733,074.43 |
| 财务费用 | 188,826.65 | -406,230.69 | -1,171,271.47 | -499,228.59 |
| 其中:利息费用 | 1,499,473.95 | 436,528.27 | 3,114,826.36 | 3,009,155.59 |
| 其中:利息收入 | 613,373.97 | 307,575.5 | 2,203,530.26 | 1,992,735.27 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 3,205,585.59 | 1,102,043.71 | -2,159,105.95 | 7,630,716.17 |
| 加:投资收益 | 670,776.86 | -581,551.39 | 10,237,398.3 | -283,479.34 |
| 资产处置收益 | -224,532.12 | -141,491.17 | 190,079.24 | 192,035.52 |
| 资产减值损失(新) | -428,623.39 | -86,809.82 | -10,578,392.04 | 46,637.99 |
| 信用减值损失(新) | -335,931.78 | -883,213.83 | -3,412,355.77 | -1,770,874.78 |
| 其他收益 | 11,042,819.18 | 5,626,292.19 | 21,615,223.57 | 11,601,669.75 |
| 四、营业利润 | 145,204,908.91 | 67,441,011.06 | 278,849,580.95 | 206,607,044.21 |
| 加:营业外收入 | 1,038,771.48 | 100,539.7 | 2,316,420.72 | 2,208,989.07 |
| 减:营业外支出 | 919,267.05 | 855,254.89 | 5,105,271.07 | 2,739,368.23 |
| 五、利润总额 | 145,324,413.34 | 66,686,295.87 | 276,060,730.6 | 206,076,665.05 |
| 减:所得税费用 | 18,140,505.32 | 7,311,050.35 | 28,356,584.95 | 22,732,726.68 |
| 六、净利润 | 127,183,908.02 | 59,375,245.52 | 247,704,145.65 | 183,343,938.37 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 127,183,908.02 | 59,375,245.52 | 247,704,145.65 | 183,343,938.37 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 115,118,078.1 | 53,725,693.38 | 227,404,091.13 | 167,914,693.97 |
| 少数股东损益 | 12,065,829.92 | 5,649,552.14 | 20,300,054.52 | 15,429,244.4 |
| 扣除非经常损益后的净利润 | 103,229,980.04 | 50,503,741.09 | 209,869,215.19 | 151,660,045.55 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.22 | 0.1 | 0.44 | 0.32 |
| (二)稀释每股收益 | 0.22 | 0.1 | 0.44 | 0.32 |
| 九、综合收益总额 | 127,183,908.02 | 59,375,245.52 | 247,704,145.65 | 183,343,938.37 |
| 归属于母公司股东的综合收益总额 | 115,118,078.1 | 53,725,693.38 | 227,404,091.13 | 167,914,693.97 |
| 归属于少数股东的综合收益总额 | 12,065,829.92 | 5,649,552.14 | 20,300,054.52 | 15,429,244.4 |
| 公告日期 | 2025-08-09 | 2025-04-28 | 2025-03-27 | 2024-10-15 |
| 审计意见(境内) | | | 标准无保留意见 | |